Back to top

Image: Bigstock

Here's What Key Metrics Tell Us About BrightSpring Health Services, Inc. (BTSG) Q3 Earnings

Read MoreHide Full Article

BrightSpring Health Services, Inc. (BTSG - Free Report) reported $4.21 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 26.4%. EPS of $0.54 for the same period compares to $0.30 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $3.86 billion, representing a surprise of +9.17%. The company delivered an EPS surprise of +10.2%, with the consensus EPS estimate being $0.49.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how BrightSpring Health Services, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenues- Services: $480.81 million versus $485.13 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +31% change.
  • Revenues- Products: $3.73 billion versus the four-analyst average estimate of $3.39 billion. The reported number represents a year-over-year change of +25.8%.
  • Segment Adjusted EBITDA- Provider Services: $79 million compared to the $80.05 million average estimate based on two analysts.
  • Segment Adjusted EBITDA- Pharmacy Solutions: $202 million compared to the $185.07 million average estimate based on two analysts.

View all Key Company Metrics for BrightSpring Health Services, Inc. here>>>

Shares of BrightSpring Health Services, Inc. have returned +5.2% over the past month versus the Zacks S&P 500 composite's +0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Published in